Title : Long-term effect of galantamine on cognitive function in patients with Alzheimer's disease versus a simulated disease trajectory: an observational study in the clinical setting - Nakagawa_2017_Neuropsychiatr.Dis.Treat_13_1115 |
Author(s) : Nakagawa R , Ohnishi T , Kobayashi H , Yamaoka T , Yajima T , Tanimura A , Kato T , Yoshizawa K |
Ref : Neuropsychiatr Dis Treat , 13 :1115 , 2017 |
Abstract :
BACKGROUND: Long-term maintenance of cognitive function is an important goal of treatment for Alzheimer's disease (AD), but evidence about the long-term efficacy of cholinesterase inhibitors is sparse. To evaluate the long-term efficacy and safety of galantamine for AD in routine clinical practice, we conducted a 72-week post-marketing surveillance study. The effect of galantamine on cognitive function was estimated in comparison with a simulated disease trajectory. PATIENTS AND |
PubMedSearch : Nakagawa_2017_Neuropsychiatr.Dis.Treat_13_1115 |
PubMedID: 28458553 |
Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K (2017)
Long-term effect of galantamine on cognitive function in patients with Alzheimer's disease versus a simulated disease trajectory: an observational study in the clinical setting
Neuropsychiatr Dis Treat
13 :1115
Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K (2017)
Neuropsychiatr Dis Treat
13 :1115